XTX Topco Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$513,025
-8.7%
5,727
-13.2%
0.09%
-12.9%
Q2 2023$561,924
+88.7%
6,600
+83.4%
0.10%
+62.9%
Q1 2023$297,817
+3.4%
3,599
-1.7%
0.06%
+1.6%
Q4 2022$288,095
-15.3%
3,663
-28.1%
0.06%
-47.0%
Q2 2021$340,000
+9.0%
5,096
+81.5%
0.12%
-24.3%
Q1 2021$312,0002,8070.15%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders